Hair transplant candidacy — medical workup, partial transplants and non-surgical options first

Key facts

• Diagnosis first: not all hair loss suits a transplant
• Stable pattern loss and good donor hair are key
• Partial transplants can treat hairline, temples or crown
• Medical therapy protects native hair before and after surgery
• Manhal provides workup and referral, not transplant surgery

Why a medical workup comes first

A hair transplant moves follicles from a donor area, usually the back and sides of the scalp, to thinning areas. It does not stop ongoing hair loss in the surrounding native hair. If the cause of hair loss is not identified, a person may undergo surgery for a condition that would have responded to medicine, or that is unsuitable for transplantation, such as active alopecia areata, diffuse thinning from iron deficiency or thyroid problems, or active scarring alopecia. Dr. Abdullah Anis reviews your history, examines the scalp with trichoscopy, arranges blood tests and, when needed, a biopsy, so the diagnosis is clear before any surgical decision.

Who is usually a good candidate

Good candidates generally have androgenetic alopecia that has been stable for some time, sufficient healthy donor hair, realistic expectations and good general health. Age matters, because hair loss in younger men often continues to progress, and a transplant done too early may leave an unnatural pattern later. Women with pattern thinning can be candidates when the donor area is strong and the thinning is localised, but diffuse thinning often responds better to medical treatment. People with scarring alopecia need the disease to be inactive for a sustained period before transplantation is considered, and grafts may survive less well.

Partial hair transplant: when it makes sense

A partial hair transplant, sometimes searched as زراعة الشعر الجزئية, treats a specific area, such as the frontal hairline, temples or crown, rather than the whole scalp. It can suit people with limited, well-defined thinning, those wanting to refine a hairline, or those with a stable bald patch from an old injury or burnt-out scarring alopecia. Because native hair around the treated area can continue to thin, medical therapy is often recommended to protect it. Dr. Abdullah Anis discusses whether a partial approach fits your pattern and how it relates to long-term planning.

Non-surgical options to try first

For many people, medical treatment can slow hair loss and improve density, sometimes enough that a transplant is postponed or not needed. Options include topical or low-dose oral minoxidil, finasteride or dutasteride for suitable men, anti-androgen medicines for selected women, PRP injections, and correcting iron, vitamin D or thyroid problems. These treatments typically need three to six months to show change. Even if you proceed to surgery later, continuing medical treatment usually helps maintain native hair and the overall result. A written plan with review dates makes it easier to judge progress.

Referral and questions to ask a surgeon

Manhal does not perform hair transplant surgery. If transplantation is appropriate, Dr. Abdullah Anis can advise on timing and refer you, sharing your diagnosis and treatment history. When choosing a surgeon, ask who performs each step of the procedure, whether they are DHA-licensed for it, how many grafts are realistic for your donor area, the expected recovery and how future hair loss will be managed. Seek medical review promptly after any transplant if you develop increasing pain, swelling, redness, pus or fever, which may indicate infection. Dr. Anis can continue your medical hair loss treatment before and after surgery.

Hair loss can come from genetics, hormones, iron or thyroid issues, stress, scalp inflammation or autoimmune alopecia. A dermatologist identifies the type before recommending treatment.

Prepared by the Manhal Medical Center editorial team · Updated: 2026-10-18 · Treating specialist: Dr. Abdullah Anis

This page is general information and does not replace a consultation. Suitability, risks and results vary between patients.